As monotherapy: When diet and exercise do not provide adequate glycemic control and when metformin is not suitable due to intolerance or contraindications
New Frontiers in Lp(a)-Targeted Therapies
Ideally, the findings of the above animal experiments require validation in clinical settings, to determine whether metformin can be applied to treat OA in humans
513,514 In contrast, genetic deletion of 5-LO in P301S tau mice 515 or pharmacologic inhibition of 5-LO with zileuton, 512,516,517 both resulted in significant reduction of tau phosphorylation and glial cell activation and thus ameliorated cognitive deficits
Anti-obesity drug therapy can be offered as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or 2730 kg/m 2 in the presence of at least one weight-related comorbidity, e.g., dysglycemia, hypertension, dyslipidemia, or obstructive sleep apnea
Together, these two incretins contribute to metabolic homeostasis, preventing both hyperglycemia and hypoglycemia, mitigating dyslipidemia, and reducing the risk of cardiovascular diseases in individuals with type 2 diabetes and obesity
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
